Angiogenesis and autosomal dominant polycystic kidney disease

Area of Science:

• Nephrology
• Vascular Biology
• Genetics

Background:

• Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder causing kidney cysts and often leading to end-stage renal disease.
• Current ADPKD treatments focus on cyst growth mechanisms like cell turnover and fluid secretion.
• An alternative therapeutic avenue involves targeting the blood vessels that support cyst development.

Purpose of the Study:

• To explore the role of blood vessels and angiogenic growth factors in ADPKD progression.
• To review current research on manipulating vascular endothelial growth factor (VEGF) in ADPKD models.
• To discuss the potential of targeting angiogenesis as a novel treatment strategy for ADPKD.

Main Methods:

• Review of existing literature on ADPKD pathogenesis and vascularization.
• Analysis of studies investigating the impact of VEGF and angiopoietin families in ADPKD.
• Discussion of experimental approaches manipulating angiogenesis in ADPKD.

Main Results:

• Evidence suggests that blood vessels and growth factors like VEGF are integral to ADPKD cyst progression.
• Experimental manipulation of VEGF has shown potential in preclinical ADPKD models.
• Angiogenesis plays a significant role in providing support for cyst growth in ADPKD.

Conclusions:

• Targeting angiogenesis, particularly through modulating VEGF, presents a promising novel therapeutic strategy for ADPKD.
• Understanding the interplay between vascular networks and cyst growth is crucial for developing effective ADPKD treatments.
• Future research should focus on translating anti-angiogenic strategies into clinical applications for ADPKD management.